LA PrEP Impact and Cost-effectiveness (TEAMS)
ConditionHiv
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorInstitute of HIV Research and Innovation Foundation, Thailand
About this trial
This study will have three components:
1. Discrete choice experiments 2. Analysis of routine service data 3. Impact and cost-effectiveness analyses using results from 1 and 2
Eligibility criteria
Qualifiers
Minimum age of 18 years
Individual assigned male at birth reporting sex with men in the past 12 months
Self-reported HIV-negative MSM and TGW who either report interest in PrEP use, current PrEP use, or past PrEP use
Permit audio recording during the interview and/or discussion.
Disqualifiers
Not willing to participate in the study
Trial design
Treatments tested in this trial
- In-depth interviews (IDI)
- Focus group discussion (FGD)
Treatment groups
10,720 Participants
are divided into 1 treatment groupSponsors and collaborators
Institute of HIV Research and Innovation Foundation, Thailand
Lead sponsor
Erasmus Medical Center
Collaborator
Source ClinicalTrials.gov